Jul. 3 at 10:33 AM
$CTMX 21M share short, 14% of float. Great Phase 1 results with more upside potential within 6months to 1 year. Pipeline filled with reputable big bio partners who could easily buy them out. Smart money institutions recently invested in the capital raise (Same ones that invested in IMMU, taken over by Gilead for 88/share. Happy I repositioned even larger after this recent retracement after my profit taking sales at
$2.95. Major short squeeze potential on horizon